Brief: Syros Pharmaceuticals To Present Initial Data From Select-Aml-1 Phase 2 Trial At 64Th Ash Annual Meeting
03/11/2022 14:25
Nov 3 (Reuters) - Syros Pharmaceuticals Inc SYRS.O :
* SYROS PHARMACEUTICALS TO PRESENT INITIAL DATA FROM
SELECT-AML-1
PHASE 2 TRIAL AT 64TH ASH ANNUAL MEETING
Source text for Eikon: ID:nBw2DJnPta
Further company coverage: SYRS.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Syros Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney
Syros Pharmaceuticals hits record low on QIAGEN deal termination and leadership changes
U.S. STOCKS ON THE MOVE-Charter Communications, BioNTech, Big US banks
U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune
Syros falls after blood cancer drug fails in late-stage trial